首页> 外文期刊>Biochemical Pharmacology >Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A(2) from Bothrops jararacussu snake venom.
【24h】

Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A(2) from Bothrops jararacussu snake venom.

机译:结构和功能表征的酸性血小板聚集抑制剂和降血压磷脂酶A(2)从Bothrops jararacussu蛇毒。

获取原文
获取原文并翻译 | 示例
           

摘要

An acidic (pI approximately 4.5) phospholipase A(2) (BthA-I-PLA(2)) was isolated from Bothrops jararacussu snake venom by ion-exchange chromatography on a CM-Sepharose column followed by reverse phase chromatography on an RP-HPLC C-18 column. It is an approximately 13.7kDa single chain Asp49 PLA(2) with approximately 122 amino acid residues, 7 disulfide bridges, and the following N-terminal sequence: 1SLWQFGKMINYVM-GESGVLQYLSYGCYCGLGGQGQPTDATDRCCFVHDCC(51). Crystals of this acidic protein diffracted beyond 2.0A resolution. These crystals are monoclinic and have unit cell dimensions of a=33.9, b=63.8, c=49.1A, and beta=104.0 degrees. Although not myotoxic, cytotoxic, or lethal, the protein was catalytically 3-4 times more active than BthTX-II, a basic D49 myotoxic PLA(2) from the same venom and other Bothrops venoms. Although it showed no toxic activity, it was able to induce time-independent edema, this activity being inhibited by EDTA. In addition, BthA-I-PLA(2) caused a hypotensive response in the rat and inhibited platelet aggregation. Catalytic, antiplatelet and other activities were abolished by chemical modification with 4-bromophenacyl bromide, which is known to covalently bind to His48 of the catalytic site. Antibodies raised against crude B. jararacussu venom recognized this acidic PLA(2), while anti-Asp49-BthTX-II recognized it weakly and anti-Lys49-BthTX-I showed the least cross-reaction. These data confirm that myotoxicity does not necessarily correlate with catalytic activity in native PLA(2) homologues and that either of these two activities may exist alone. BthA-I-PLA(2), in addition to representing a relevant molecular model of catalytic activity, is also a promising hypotensive agent and platelet aggregation inhibitor for further studies.
机译:通过离子交换色谱法在CM-琼脂糖柱上分离酸性(pI约为4.5)磷脂酶A(2)(BthA-I-PLA(2)),然后在RP-HPLC上进行反相色谱分离C-18色谱柱。它是一个约13.7kDa的单链Asp49 PLA(2),具有约122个氨基酸残基,7个二硫键和以下N端序列:1SLWQFGKMINYVM-GESGVLQYLSYGCYCGLGGQGQPTDATDRCCFVHDCC(51)。这种酸性蛋白质的晶体衍射超过2.0A分辨率。这些晶体是单斜晶体,其晶胞尺寸为a = 33.9,b = 63.8,c = 49.1A和beta = 104.0度。尽管没有肌毒性,细胞毒性或致死性,但该蛋白的催化活性是BthTX-II的3-4倍,BthTX-II是来自同一毒液和其他Bothrops毒液的基本D49肌毒性PLA(2)。尽管它没有显示毒性活性,但是它能够诱导非时间依赖性的水肿,这种活性被EDTA抑制。此外,BthA-I-PLA(2)在大鼠中引起了降压反应并抑制了血小板聚集。催化,抗血小板和其他活性已通过4-溴苯甲酰溴的化学修饰而取消,4-溴苯甲酰溴已知与催化位点的His48共价结合。针对粗制野菜芽孢杆菌(B. jararacussu)毒液产生的抗体识别出该酸性PLA(2),而抗Asp49-BthTX-II识别力很弱,而抗Lys49-BthTX-I显示出最少的交叉反应。这些数据证实,肌毒性不一定与天然PLA(2)同源物中的催化活性相关,并且这两种活性中的任何一种都可能单独存在。 BthA-I-PLA(2)除了代表相关的催化活性分子模型外,还是有希望的降压药和血小板凝集抑制剂,需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号